Health control:No

5 trials

Sponsors

The Second Xiangya Hospital of Central South University, the First Affiliated Hospital of Anhui Medical University, West China Hospital of Sichuan University, Peking university third hospital cadiology department, China-Japan Friendship Hospital

Conditions

Parkinson's DiseaseSchizophreniaacute coronary syndromelupus nephritispsoriasis

Early Phase 1

Noninvasive Neuromodulation in the Treatment of Parkinson’s Disease with Postrual Disorder and Exploration in the Mechanism

RecruitingChiCTR2300072337

the First Affiliated Hospital of Anhui Medical UniversityParkinson's Disease

Start: 2022-12-01Updated: 2023-06-18

Phase 4

Study on the Effect and Mechanism of Targeted Therapy of Telitacicept on Peripheral Blood Immune Cell Subsets in Patients with Lupus Nephritis

Active, not recruitingChiCTR2500095088

West China Hospital of Sichuan Universitylupus nephritis

Start: 2025-01-01Updated: 2025-01-06

Unknown Phase

The association of serum IL-18 with cathecholamines and adverse cardiovascular events in the acute coronary syndrome patients: a prospective observational cohort study

Active, not recruitingChiCTR-OOC-15005913

Peking university third hospital cadiology departmentacute coronary syndrome

Start: 2015-02-09Updated: 2017-04-18

The effect of antipsychotic on first-onset drug-naive schizophrenia: brain image, DNA methylation and gene expression study

Active, not recruitingChiCTR1800014844

The Second Xiangya Hospital of Central South UniversitySchizophrenia

Start: 2012-10-01Updated: 2018-02-12

Mechanism of the Therapeutic Effects of Qingre Liangxue Formula on Psoriasis Vulgaris: a multi-Omics Analysis

Active, not recruitingITMCTR2025000088

China-Japan Friendship Hospitalpsoriasis

Start: 2023-08-16Updated: 2025-02-03